Rooshi Nathwani
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Non-selective beta-blocker use in cirrhosis: the additional benefit in preventing secondary infections.
Journal: Frontline gastroenterology
Published: February 17, 2021
Suppressor CD4+ T cells expressing HLA-G are expanded in the peripheral blood from patients with acute decompensation of cirrhosis.
Journal: Gut
Published: January 08, 2021
Effect of COVID-19 lockdown on alcohol consumption in patients with pre-existing alcohol use disorder.
Journal: The lancet. Gastroenterology & hepatology
Published: July 23, 2020
Letter: liver disease and COVID-19-not the perfect storm.
Journal: Alimentary pharmacology & therapeutics
Published: July 14, 2020
Activation and transcriptional profile of monocytes and CD8+ T cells are altered in checkpoint inhibitor-related hepatitis.
Journal: Journal of hepatology
Published: April 08, 2020
Non-Alcoholic Fatty Liver Disease and Vascular Disease.
Journal: Current vascular pharmacology
Published: February 04, 2020
Current and future pharmacological therapies for managing cirrhosis and its complications.
Journal: World journal of gastroenterology
Published: December 07, 2018
CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.
Journal: Gut
Published: March 21, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026